Bristol-Myers Squibb Co.
BMY
NYSE
IPO1952
about BMY
Bristol-Myers Squibb Co. is a leading pharmaceutical company focused on developing innovative medicines for diseases such as cancer, immunology, and cardiovascular disorders, providing life-saving treatments to patients worldwide.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $59.67 | $60.06 | $58.75 | $120.3B | 9.40M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$1.08 | n/a | n/a | 25.48% | 17.96% | 0% |